CAJ | 학술논문

利用DEA-Tobit两步法对中小板上市的创新型医药生物企业先测算了创新效率，进一步探讨了创新支持政策对创新效率的影响。实证研究表明，大部分企业技术效率不高，纯技术效率有提高，规模效率未达到有效；高强度的政府补贴提高了企业的纯技术效率；税费返还则对纯技术效率有负向影响；创新平台显著提高了技术效率和规模效率。
이용DEA-Tobit량보법대중소판상시적창신형의약생물기업선측산료창신효솔，진일보탐토료창신지지정책대창신효솔적영향。실증연구표명，대부분기업기술효솔불고，순기술효솔유제고，규모효솔미체도유효；고강도적정부보첩제고료기업적순기술효솔；세비반환칙대순기술효솔유부향영향；창신평태현저제고료기술효솔화규모효솔。
As innovative enterprises are important carriers of innovation-driven development strategy in China , innovation platforms can effectively stimulate innovation activities .SME Board pharmaceutical and biotech innovative companies are set as samples and the innovative efficiency is assessed with a DEA -Tobit two-step model.The impact of innovation support policy on innovation efficiency is also discussed .An em-pirical study shows that most of the enterprises have low technical efficiency .Though the pure technical ef-ficiency has improved , the scale efficiency is still low .What's more, though high strength of government subsidies improves their pure technical efficiency , tax return has negative influence on it .Innovation plat-forms improve both technical and scale efficiency .Thus, five suggestions are made based on our study .